pimozide has been researched along with Ptosis, Eyelid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Schellekens, KH; Wauquier, A | 1 |
| Arthurs, B; Codère, F; Dresner, S; Flanders, M; Gauthier, S; Stone, L | 1 |
2 other study(ies) available for pimozide and Ptosis, Eyelid
| Article | Year |
|---|---|
Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperature Regulation; Body Weight; Catalepsy; Dextroamphetamine; Dogs; Escape Reaction; Female; Guinea Pigs; Haloperidol; Humans; Lethal Dose 50; Male; Mice; Norepinephrine; Penfluridol; Pimozide; Piperidines; Rats; Self Stimulation; Stereotyped Behavior; Tranquilizing Agents | 1975 |
Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
Topics: Baclofen; Blepharoptosis; Blepharospasm; Botulinum Toxins; Drug Evaluation; Eyelid Diseases; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pimozide | 1987 |